Best Medicare Part D Prescription Drug Plans Of 2025
Over 66% of U.S. adults use at least one prescription drug, according to data gathered by the Health Policy Institute at ...
Medicare Drug Coverage Is Often Inadequate—Here’s Why
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
Commonwealth Fund4d
Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
MedCity News4d
Could the Trump Administration Change the Medicare Drug Price Negotiation Program?
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...
JD Supra12h
Mintz IRA Update — Operationalizing the Medicare Prescription Payment Plan and Medicare Inflation Rebate Program
In addition to the Part D Benefit Redesign, the IRA’s Medicare Prescription Payment Plan (MPPP) went into effect beginning January 1, 2025. The ...
California Democrats clash over how to rein in drug industry middlemen
A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.
Capital Public Radio1d
Top California Democrats clash over how to rein in drug industry middlemen
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
VI Consortium2d
DEA and USVI Agencies Launch Prescription Drug Drop Box Program to Combat Misuse
The program establishes five drop box locations across the U.S. Virgin Islands—two in St. Croix, two in St. Thomas, and one ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Diet drug boom weighs heavily on state budgets
The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...
How key drugs boosted Gilead — and how the Inflation Reduction Act could deliver a billion-dollar hit
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
Benefits Pro2d
Wells Fargo and Johnson & Johnson lawsuits: Lessons health plans can learn
We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...